Boston Scientific Corporation

Equities

BSX

US1011371077

Market Closed - Nyse Other stock markets 04:00:02 2026-05-08 pm EDT			5-day change	1st Jan Change
53.93 ^USD	-4.67%		-4.55%	-43.44%

May. 07	Boston Scientific to Update Pacemakers in Recall, FDA Says	DJ
May. 07	US FDA issues recall of Boston Scientific heart devices	RE

Transcript : Boston Scientific Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 05

Published on 01/13/2025 at 08:15 pm EST

S&P Capital IQ

Presenter Speech
Robert Marcus (Analysts)

Good afternoon, everyone. If you want to take a seat. Robbie Marcus, I'm the med tech analyst at JPMorgan, saving the best for last here to wrap up day 1 of

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Boston Scientific Corporation

May. 07	Boston Scientific to Update Pacemakers in Recall, FDA Says	DJ
May. 07	US FDA issues recall of Boston Scientific heart devices	RE
May. 07	Penumbra is a 'Strong' Strategic fit for Boston Scientific, RBC Says	MT
Apr. 29	Boston Scientific Shares Fall After Daiwa Securities Downgrade	MT
Apr. 29	HEALTH ROUNDS-Procedure using Boston Scientific device tops medication for heart rhythm problem	RE
Apr. 29	Wall Street's Wednesday Test Is Bigger Than Tech
Apr. 29	Daiwa Securities Downgrades Boston Scientific to Neutral From Outperform, Adjusts PT to $60 From $83	MT
Apr. 29	Analyst recommendations: Sysco, T-Mobile, Booking, Ge Vernova, Teradyne…
Apr. 27	UBS Adjusts Boston Scientific Price Target to $95 From $105, Maintains Buy Rating	MT
Apr. 27	Argus Research Adjusts Boston Scientific Price Target to $95 From $115, Maintains Buy Rating	MT
Apr. 26	Boston Scientific Corporation Provides Data At Heart Rhythm 2026 Highlight Key Boston Scientific Therapies	CI
Apr. 23	Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says	MT
Apr. 23	Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating	MT
Apr. 23	Deutsche Bank Cuts Price Target on Boston Scientific to $75 From $90, Keeps Buy Rating	MT
Apr. 23	Truist Lowers Price Target on Boston Scientific to $85 From $90, Keeps Buy Rating	MT